Riskpilot← Back to searchSign inGet full accessVIVIBENE AS
ASActiveOrg 922412693Bekkestuveien 21C, 1357 BekkestuaRetail sale of pharmaceutical products · NACE 4773Est. 20190 employees
Revenue 2025
NOK 3,8M
-1% vs 2024
EBITDA margin
-5.1%
-200% vs 2024
Equity ratio
76.2%
Financial strength
Net profit 2025
NOK -234K
-101% vs 2024
| Revenue | NOK 3,8M | -1% |
| EBITDA | NOK -191K | -200% |
| Net profit | NOK -234K | -101% |
| Total assets | NOK 876K | -23% |
| Equity | NOK 668K | -26% |
| Employees | 0 | — |
Legal name
VIVIBENE AS
Org number
922412693
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
19. mars 2019
Share capital
NOK 649 500
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Import og nettsalg av produkter innen helse og miljø etc og hva som måtte stå i forbindelse med dette, samt delta i annen virksomhet.
Address
Bekkestuveien 21C, 1357 Bekkestua
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 173 | 1 035 | 1 613 | 2 612 | 3 442 | 3 817 | 3 773 |
| Staff expenses | −1 | −0 | −3 | −12 | −24 | −19 | −6 |
| EBITDA | −87 | −31 | 156 | 522 | 58 | −64 | −191 |
| Depreciation & amort. | −0 | −20 | −20 | −23 | −23 | −23 | −23 |
| EBIT | −87 | −51 | 136 | 499 | 35 | −87 | −214 |
| Net financials | 0 | 0 | −8 | −27 | −25 | −31 | −20 |
| Profit before tax | −87 | −51 | 129 | 472 | 10 | −118 | −234 |
| Tax | −0 | −0 | −0 | 102 | 2 | −2 | −0 |
| Net profit | −87 | −51 | 129 | 370 | 8 | −116 | −234 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 609 | 599 | 729 | 1 259 | 1 208 | 1 143 | 876 |
| Equity | 563 | 512 | 640 | 1 010 | 1 018 | 902 | 668 |
| Long-term debt | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Short-term debt | 46 | 87 | 89 | 249 | 188 | 241 | 208 |
| Total debt | 46 | 87 | 89 | 249 | 190 | 241 | 208 |
EBITDA margin
-5.1%
This company
15.8%
Market median
-132% vs market
20192025
Equity ratio
76.2%
This company
38.2%
Market median
+99% vs market
20192025
Return on equity
-35.0%
This company
18.4%
Market median
-290% vs market
20192025
Net profit margin
-6.2%
This company
8.1%
Market median
-177% vs market
20192025
Asset turnover
4.31×
This company
1.12×
Market median
+285% vs market
20192025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20192025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Aas As | Company | 25.0% | 25.0% | 2022 |
| Individual | 25.0% | 25.0% | 2022 | |
Tannlege Hermansen Holding As | Company | 25.0% | 25.0% | 2022 |
| Individual | 25.0% | 25.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VIVIBENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thor Kristian Andresen | Chairman | 0 companies |
| Pål Hermansen | Board of Directors | 0 companies |